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INTRODUCTION
The purpose of this paper is to model the determinants of health care expenditures (HCE) and
investigate the short-run, long-run equilibrium dynamic causal relationship between health care
and income per capita within the time series framework from 1981 to 2014 in Malaysia. For
appropriate model specification and forecasting accuracy, different econometric diagnostic tests
were applied. Ordinary least square (OLS) method was used to estimate the long run parameters.
Long run co-integration was investigated by Auto-Regressive Distributed Lag Model (ARDL)
Bound approach, whereas, for causality analysis the Engle-Granger method was used. Income,
population structure, and population growth was identified as the significant contributing factors
to explain variations in HCE. The estimated income elasticity for HCE was found 0.99 < 1
showing health care was a necessity. The results confirmed a feed-back hypothesis between health
expenditure and income per capita.
Money spending and health care expenditure relationship has long been established (Getzen,
2014). Better health has been identified as an important factor to raise economic growth and
increased productivity. A healthy population of any country is of important importance and
has positive connections to economic growth (Sachs, 2002; Khan et al., 2015). However, rapidly
growing HCE is a matter of grave concern for policy and decision makers across countries
in the world. The fast growth rate of health care spending exerts pressure on various sectors
of the economy, which might slow down the economic growth sustainability (Jakovljevic and
Milovanovic, 2015; Jakovljevic, 2016) create poverty trap, as more out-of-pocket health expenditure
hugely affects household income (Khan et al., 2015).
Health Care Expenditure and the Malaysia Case
Malaysia with a total land area of 329,758 square kilometers is one of the leading and fast growing
high middle-income economies in the Southeast Asian countries. The total population of the
country is approximately 29,717million which is distributed within 14 states, with a per capita gross
national income of US $22 (international PPP); and life expectancy rate ranging from 72 to 76 years
at birth of male and female respectively. It spends US$ 938 billion total on health with a growth rate
of more than 4.49% on HCE (WHO, 2013). Malaysia, a rapidly fast growing developing economy
in the Southeast Asian countries, spent 2.94, and 4.49% of GDP on its total health expenditure,
in 1997 and 2012, respectively. The overall per capita spending over the same period was US
$223 and US$463, respectively. In 2012, the sector-wise share of health care financing expenditure
was: Ministry of health 44%; out-of-pocket 37%; private insurance 7%; other federal agencies
4% (MOH, 2014). The health expenditure growth rate of 4.49%, when compared to the annual
GDP growth rate of 6%, shows the persistent rise in growth of health expenditure which might
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cause slowing down growth process of economy to a snail’s
pace. This might exert burden on country’s GDP in the form
of deficit budget, provision of health care services, and patients
out of pocket finances. Thus, it is needed to model and forecast
determinants of health care expenditure and future trends in the
health care spending, in order to devise appropriate policies to
control the rapidly growing HCE growth, equitable health care
services provision, and affordable treatments to the people of
Malaysia.
This paper aims at, modeling the determinants of health care
expenditure (HCE) and the effects of contributing factors of
increased health care spending on economic growth by using
annual data ranging from 1981 to 2014 in Malaysia.
Motivation of the Study
Based on the current literature survey, this study is first of its
kind which attempts to model and investigate factors influencing
HCE over an extended time period in Malaysia economy using,
ordinary least square (OLS), Autoregressive Distributed Lag
Model (ARDL) using annual time series data ranging from 1981
to 2014. We investigate time series properties such as unit root
and co-integration between health care and income per capita.
Besides, the causality is also examined through Engle Granger
(1969) test to find out the direction of causation and for policy
implications. The remainder paper is structured as follows:
Section 2 is devoted to an overview of the existing literature
on the topic. In section 3, data and sources of data; variables and
their measurements are discussed. Moreover, model specification
and methodology is also included in this section. Section 4
discusses estimated results and section 5 concludes with some
policy implications and suggestions.
LITERATURE REVIEW
Introduction
Rapid population growth has raised serious concerns about the
improvements in health status of the general public, health
care systems‘ financial sustainability, both in developed and
developing countries as well. Over the last couple of decades,
it has been a point of debate, both for applied econometricians
and health economists to analyze HCE and its determinants.
In addition to that, it has also been very tempting to growth
economists and to theoretical and applied econometricians to
study economic growth and factors affecting economic growth.
The applied econometricians and economists made attempts to
model and analyze the relationship between HCE, determinants
of HCE, and GDP per capita, including their factors by
modeling and analyzing the association between HCE and other
non-economic, social and demographic variables at individual
country levels and in a panel of countries. Further, accumulated
review of the literature on the subject is overviewed in the
sections discussed below.
Major Factors of Health Care Expenditure
Income as a Driver of Health Care Expenditure
Numerous studies investigated the HCE and income relationship
in a cross-sectional framework with principal findings (1) Income
as a potential factor responsible for explaining variations in level
and growth of HCE across countries; (2) health expenditure
a luxury good with an income elasticity above one (Kleiman,
1974; Newhouse, 1977; Parkin et al., 1987; Gbesemete and
Gerdtham, 1992; Gerdtham et al., 1992a,b). This strand of
literature emphasized on measuring the size of income elasticity
of health care (HC), and the policy effects for the investing and
delivery of HC resources. On one hand, supporters of health
spending being a luxury commodity claim that it is a good
same as other goods and should be put up for market forces.
Whereas, advocates of HCE being a necessity, stress the role of
government control and intervention in the delivery of health
care (Culyer, 1989; Di Matteo, 2003). Many of the past studies
either have the issue of variables omission and conversion factor
procedures or some methodological problems (Kleiman, 1974;
Newhouse, 1977). These studies considered income as a main
contributing factor in explaining variations in HCE. However,
many researchers in the aftermath incorporated non-income
variables as determinants of HCE and investigated the effects
of these variables on HCE. Age structure of population was
identified as a key indicator to explain changes in HCE across
nations (Leu, 1987; Cuyler, 1988). The share of population lees
than 15 years of age and elderly population such as 65 years and
over or up to 75 years of age was estimated in the model while
explaining changes in the HCE per capita. It was noted that, these
variables showed marginal influence on HCE (Grossman, 1972;
Leu, 1986; Di Matteo and Di Matteo, 1998).
Technology’ Role in Health Care Expenditure
Technological progress is one of the key factors to explain
variations of HCE (Newhouse, 1992). However, little attention
has been paid to the research in order to study the effects of
technological progress on HCE, due to the non-availability of
an appropriate proxy to capture variations in the medical care
technologies. Various proxies have been used in the past studies,
such as surgical methods and specific equipment (Baker and
Wheeler, 1998; Weil, 2007), health care specific research and
development expenditure (Okunad and Murthy, 2002); infant
mortality and life expectancy at birth (Dreger, 2005); time index
as a proxy for the impact of technology change (Gerdtham
and Löthgren, 2000); time-specific intercepts (Di Matteo, 2004).
Innovations in technology along with weak cost containment
policy were identified as a main contributing factor in increasing
health care cost. Major improvements in the health-related
technologies, in general, increase health care (Bodenheimer,
2005). The addition of new low cost per patient per year
technology to the health care system increases spending on health
and health care, because more people are being treated (Lubitz,
2005). Advances and diffusions in medical care technology into
the health care systems were the major responsible factors for
growing expenditure in health care (Newhouse, 1992). However,
there was a conflicting and complex relationship betweenmedical
technology and HCE (Sorenson et al., 2013). Health care
technology increased survival rates on one hand, but on the
other hand it has rapidly increased the cost pertaining to health
care as a ratio to GDP (Chandra and Skinner, 2012). Properly
managed use of technology, especially mobile technology could
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be a major driver to cut cost, improve safety, and as a source of
improved decision making for health care professionals (Junglas
et al., 2009). Medium and long term forecast models try to
elucidate the responsible and driving factors of heath care
spending for more clear policy choices available. Expenditure
growth is more related to budget decisions. Varying innovative
technologies contributed more to growth in the medium term
as was the case with targeted biologicals (Jakovljevic, 2015),
diagnostic radiology (Rankovic´ et al., 2013) and radiation therapy
of cancer (Jakovljevic et al., 2014). Various risk factors such as
obesity, and variations in the chronic diseases prevalence turned
out to be important in the long term forecasting (Thorpe et al.,
2004).
Aging Population and Health Care Expenditure
It is generally anticipated that aging population would be a
key factor in health care system and HCE in the near future
(United States Congressional Budget Office, 2007). It is also
likely that future trends in the health care and long run care
would be different (Spillman and Lubitz, 2000). The impact
of aging population in the health care spending growth has
been extensively investigated in the past studies (Zweifel et al.,
1999; Hogan et al., 2001). The Non-significant impact of aging
population was found on total per capita HCE (Hoover et al.,
2002; Tchoe and Nam, 2010). However, Breyer and Felder (2006),
Schulz et al. (2004), (Ogura and Jakovljevic (2014) and Khan
et al. (2015) identified aging population as a contributing factor
of accruing health care costs; a positive relationship between
aging and HCE in short run (Bech et al., 2011). As population
ages, total health care spending and expenditure on care of
elderly growing (Häkkinen et al., 2008; Mao and Xu, 2014).
Aging population was found as a major driver for the health
care demand, and thus, an increasing source of health care
spending (Reinhardt, 2003). Aging population and aggregate
HCE were found to be negatively correlated (Palangkaraya and
Yong, 2009). In contrast, the micro-simulation method study
showed that there is no sizable impact of aging on health care
spending, but the upward movements in the variations were
because of prevailing practices (Dormont et al., 2006). However,
some studies found that the costs associated with age profile
have a tendency to increase to reach a certain level but decline
after that level (Martins et al., 2006; Przywara, 2010). Other
micro-level studies, (Lubitz et al., 1995; Seshamani and Gray,
2004; Breyer and Felder, 2006) focused on testing whether age
or time to death (hereafter, TTD) is responsible for explaining
increasing trends of variations in health care spending. Several
individual-level studies has suggested that acute health care cost
increased as TTD reached nearer and nearer, (Zweifel et al.,
1999; Hoover et al., 2002; Breyer and Felder, 2006). However, no
significant association found between general practitioners and
TTD (Madsen et al., 2002).
A little attention has been paid to find the relationship between
the costs of age profile of dying and health care expenditure
(Lubitz et al., 1995; Kovacevic´ et al., 2015). Seshamani and Gray
(2004) investigated the relationship and found that cost of dying
due to acute health care declined beyond a particular age. They
found that the reduced acute health care expenditure reflected the
possibility of aged populace hospitalization and /or minimizing
the chances of introducing intensive treatment.
In many earlier studies, population forecasts and various
assumptions were the building blocks for forecasting healthcare
or long-term health care cost, particularly, with respect to time
spent in good health (Spillman and Lubitz, 2000; Madsen et al.,
2002; Breyer and Felder, 2006; Martins et al., 2006). The results
of these studies based on time series data were dependent upon
the variations in demand as well as on supply sides. Therefore,
the estimated HCE be interpreted with respect to utilization of
health care instead of demand for health care. On the other hand,
projection results were based on certain assumptions made to
future age-specific health issues, which were supply side changes.
In most of the projections, the utilization rate of age-specific
and health care allocation was considered to be constant, and
so, could be interpreted from demand side projections. A large
portion of this ever increasing demand for medical services
appears to be driven by non-communicable prosperity diseases
even in top performing BRICS markets (Jakovljevic, 2016).
DATA, MODEL SPECIFICATION, AND
METHODS
Data Sources, Variables, and their
Description
This study used annual time series data ranging from 1981 to
2014. Data on relevant variables was collected from various data
sources such as Statistics Division Malaysia, World Development
Indicators (World Bank Group, 2014), Statistical, Economic
and Social Research and Training Centre for Islamic Countries
(SESRIC), and Asian Development Bank (ADB) and other
published reports. The variables and their description are given
in Table 1.
This study included aging population, as a key driver of HCE
because when population ages, public spending as a percentage
of GDP is likely to increase, and increased life expectancy is
TABLE 1 | Variable names and descriptions.
Variables Description Sources
gdp, gdpt−1 Gross domestic product/capita
and its lag value in real term
WDIa/WHOb/ADBc
he, het−1 Healthcare expenditure /capita
and its lagged values in real term
WDI/SESRICd/ADB
pop65+ Share of population age 65 years
and above
WDI/SESRIC/ADB
pop15 Share of the population under 15
years
WDI/SESRIC/ADB
Le Life expectancy WDI/SESRIC/ADB
Popgw Population growth rate WDI/SESRIC/ADB
aWDI, World Development Indicators (World Development Indicators (WDI), December
2015).
bWHO, World Health Organization (http://www.who.int/GHO/).
cADB, Asian Development Bank (http://www.adb.org/data/statistics).
dSESRIC, Statistical, Economic and Social Research and Training Centre for Islamic
Countries (http://www.sesric.org).
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expected to be linked to a decreasing population health status and
output (Cuyler, 1988). Life expectancy1, real per capita HCEs,
real GDP per capita, GDP growth rate2, and share of population
under age 15 years and 65 years3 and above are other variables
used in the study. The brief description and data sources are given
in the following table.
Model Specification for Health Care
Expenditures
The general HCE model can be specified as:
hcet = β0 + β1hcet−1 + β2gdpt + β3gdpt−1 + β4let + β5popt65 +
+β6popt15− + β7popgwt + ε1t (1)
gdpt = α0 + α1gdpt−1 + α2hcet + α3hcet−1 + α4let
+α5pop56+t + ε2t
4, (2)
where
hcet , hcet−1 = real per capita health care expenditure
5 at time
t and t-1
gdpt , gdpt−1 = is GDP per capita in real term at current time
and one period lag
let = is life expectancy at birth
pop+t65, pop
−
t15 = Population age 65 years and above, and age
less than 15 years and
popgwt = population growth at time t
εit = are independent and identical distributed (iid) error
terms.
In Equation (1), HCE acts as an endogenous variable (hect),
a function of GDP per capita and other exogenous variables
explained as above. In the Equation (2), real GDP per capita
(gdpt) acts as endogenous and HCE as exogenous variable with
other explanatory variables.
The β1 and β3 are adjustment parameters that could be
converged to the equilibrium level if there is any shock to the
system, and its value lies between 0 and 1. According to economic
theory as the real per capita income increases, the expenditure
on healthcare is expected to rise, hence β2>0. Increasing life
expectancy indicates increased overall health conditions of the
general public of an economy that could be due to the provision
of advanced technologies in the healthcare sector, which have a
positive influence on health care spending, so β4 > 0. The β5
and β6 represent the cohort of the population under the age
group of 65 years and above and ages less than 15 years; and
as the shares of these two cohorts increase the expenditure on
health and health care is likely to increase due to more demand
1Life expectancy is used as a proxy to capture the effect of technology change on
health care expenditure. A change in the levels of life expectancy has influence
human behavior at individual and aggregate level. It also impacts fertility, human
capital, growth process (Coile et al., 2002).
2Lagged values of the health care and gdp are included as previous year values
effect current expenditures.
3Share of population under age 15 and 65+ years is used to investigate the influence
of changing population.
4Gross domestic product (GDP) is modelled in Equation (2) to find the causal
effect if any between health care expenditure and GDP.
5All the variables are transformed into natural log and model the data in the
linear log form for interpreting the estimated results in elasticities and for allowing
diminishing marginal returns to other explanatory variables.
for health care services. 0〈α1〈 1 and 0〈α3〈 1 are the adjustment
coefficients; α1〉 0 because increased health spending enhances
good health which as a result increases economic growth; α4〉 0
because increased life expectancy is a measure of technological
changes, which enhances labor force skills and efficiency. The
more the skilled and technologically well-versed labor forces the
more the efficiency which ultimately spurs GDP per capita. The
effect of Population structure on GDP per capita somewhat acts
differently and may have negative effect on GDP per capita as
more the population ages the dependency ratio increases which
affects the income per capita at household levels as well as at
country aggregate level. However, if the share of aging population
is healthy and participate actively in the economy, then economic
growth increase.
Methods
Based on the objectives of the paper, in the first step, we check
the variables for the existence of possible unit root problem in
order to get rid of spurious results and for appropriate policy
relevance. To this end, we applied ADF and PP individual unit
root tests. In the second step, we applied ARDL Bound test to find
the short and the long-run relationship between the variables.
The variables were checked through various diagnostic tests in
order to get reliable, unbiased and consistent estimates of the
parameters. Thus, at the final stage to estimate long and short
run dynamics equilibrium relation among the series, we used the
Unrestricted Vector Error Correction Model (UVECM), and the
short and the long run causality were investigated by Granger
(1969). During Causality test finally, we employed Granger
causality test to investigate the causal link between the variables.
RESULTS AND DISCUSSION
Graphical Investigations
Figure 1A showed an upward trend over time with drift. So,
the series, HCE a non-stationary series. Figure 1B showed
that GDP per capita is upward trending with non-stationarity
behavior without drift. Figure 1C of aging population exhibits
steady increase from 1981 to 2000, but afterward drifting with
a trending pattern, which clearly shows time-variance. Looking
at the above Figure 1D of population growth since 1981, no
prominent pattern exists in the data, so the data generating
process showing random walk with drift and some irregularities
during 1985 to 1995 and low growth rate in 1998, 2001 and
2008-2009.
Unit Root Test
The ADF and PP unit root test results show that the variables
are mixtures of I(0) and I(1) and no variable is found to be I(2),
however, the results are not reported here in order to save the
space and can be obtained on request.
ARDL Co-integration Results
Since the unit root tests show a mixture of I(0) and I(1) variables
and none of the variables is I(2), which is the pre-assumption for
application an ARDL bound test. The bound test results confirm
a long co-integration relationship between HCE and income per
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capita and the data series pass all the relevant diagnostic tests.
These results can be provided on request as has not been shown
due to space limitations.
Regression Results
Table 2 summarized the estimated results of the regression taking
HCE as a dependent variable, regressed on other explanatory
variables as shown in the Equation (1). All the variables
significantly affecting health expenditure, however, the impact
of GDP growth was non-significant. The estimated signs of
the variables were consistent as reported in the past literature.
Income per capita has a positive and significant influence onHCE
and the estimated elasticity value for HCE was 0.995502 < 1.
The value of income elasticity value less than one indicated that
HCE was still treated as a necessity good (Khan et al., 2015).
The highest t-ratio of income per capita showed that it was a
major contributing factor responsible for explaining variations
TABLE 2 | Model: OLS results [1981-2014 (T = 34)] Dependent variable:
lnhce.
Var Coeff SE T-ratios P-value
Constt 0.960535 0.245831 3.9073 0.00054*
Lngdpp 0.995502 0.044104 22.5713 < 0.00001*
Popgr −0.31141 0.038114 −8.1702 < 0.00001*
Pop15 −0.10281 0.018512 −5.552 0.00264*
Pop65 −0.10827 0.028645 −3.7798 0.00076*
Gdpgr 0.000317 0.001738 0.1826 0.85640
Le 0.567102 0.073540 7.71148 0.00016*
R-squared: 0.994967 and Adjusted R-squared: 0.994068.
*Shows significant at 5 percent and 1 percent significant level.
in HCE. Therefore, as the real per capita income of the general
public increases, people spend more on their health in order
to keep themselves healthier, active, and live longer lives. This
result is consistent with previous studies, conducted either at the
individual country level or as a panel of countries, for example,
(Newhouse, 1977; Parkin et al., 1987; Gbesemete and Gerdtham,
1992; Gerdtham et al., 1998; Dreger, 2005; Khan et al., 2015).
The impact of population growth and population structure was
also significant. Negative signs of the population with the age
group under 15 years and age group of 65 years and above
were according to the expectations and are consistent with the
earlier research (Khan et al., 2015). The negative influence of
the population structure showed increase dependancny ratio
on the working age group, which might put pressure on the
overall GDP of the country and on allocation of resouces to
other sectors of the economy. The possible reason could be
that people in this two cohort, spend more on their health
either from their past savings or household expenditure. The 15
years and below age group contributes lesser to the development
of the economy as they are not actively engaged in economic
activities. This age group spends more on health and earns less.
Similarly, the elderly population in the declining periods of life
are more susceptible to illness, thus, they need health care to keep
themselves healthy (Ogura and Jakovljevic, 2014; Khan et al.,
2015). This result implies that for people over age 65 proximity
of death may increase, which eventually reduces short run HCE
in Malaysia. This result is consistent with (Erdil and Yetkiner,
2009; Ogura and Jakovljevic, 2014; Khan et al., 2015). The
negative relationship between health care and population growth
could be due to the non-random pattern of the population
growth. As was obvious from the Figure 1D where the growth
rate significantly drops down over certain time periods, which
outpaces the positive effects.
FIGURE 1 | Graphical investigation. (A) Health care expenditure (1981-2014). (B) GDP Per Capita in real terms(1981-2014). (C) Aging Population (1981-2014). (D)
Population Growth (1981-2014).
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CONCLUSION
The rapid increasing pattern of HCE in Malaysia is a serious
concern for the policy makers as well as the decision makers.
The purpose of this paper is to model the determinants of
HCE and find the effects of these determinants on HCE in
the time series framewok from 1981 to 2014 in Malaysia. For
the empirical investigation, the paper used ADF, PP tests to
check for unit root issue and the ARDL approach for co-
integration. For causality between HCE and GDP per capita
Ganger VECM is applied. For long run parameters estimation
an Ordinary Least Square (OLS) regression is used. The unit
root tests confirm mixture of integrating order of the variables,
i.e., I(0) and I(1). The ARDL Bound test shows the presence of
a long run co-integration between HCE and GDP per capita.
The rgeression results confirm that income per capita has a
positive and significant effect on HCE with income elasticity for
HCE 0.999 < 1. The income elasticty value shows that HCE is
a necessity. The closest value of income elasticity for HCE to
one is the most important and intersting result of the study in
the case of Malaysia for the sampled period. This indicates that
Malaysia is the most rapidly growing economy in the Association
of southest nations (ASEAN) and in the near future would be in
the list of developed countries. Moreover, population growth and
population structure have significant negative impact on HCE.
The effect of technological changes, proxy by life expectancy
also has a positive and significant influence on HCE. Thus,
GDP per capita in real term, population growth, population
strucutre and technology is the major contribtor to explain
variations in HCE in Malaysia. The Ganger VECM results also
comfirm a bidirectional causality between HCE and real GDP
per capita.
The findings of the paper provide an insight to the policy
makers that health expenditure play a significant role in the
economic development of Malaysia. Therefore, to create healthy,
efficient, technologically skilled and productive labor force it is
suggested that encouraging HCE policies be adopted in Malaysia.
The Ministry of Health Malaysia (MOH) should provide basis
health facilities as well as promote health education to the
common people of the country with a special emphasis on rural
health.
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